We are live on ! Find out more
MM

MWG Management Portfolio holdings

AUM $81.3M
1-Year Est. Return 2.28%
This Fund
S&P 500
This Quarter Est. Return
-27.07%
1 Year Est. Return
+2.28%
3 Year Est. Return
-59.16%
5 Year Est. Return
-10.97%
10 Year Est. Return
AUM
$142M
AUM Growth
-$53.8M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BEAM icon
1
Beam Therapeutics
BEAM
$2.74B
$71.9M 50.6%
2,346,934
LYEL icon
2
Lyell Immunopharma
LYEL
$315M
$47.6M 33.5%
1,008,117
PRME icon
3
Prime Medicine
PRME
$558M
$22.6M 15.9%
1,835,876

Similar funds

MWG Management's Q1 2023 Portfolio in Review

As of Q1 2023, MWG Management held 3 positions worth $142M, down 27% from $196M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 0%. MWG Management opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • MWG Management's ten largest holdings make up 100% of its $142M portfolio in Q1 2023.
  • MWG Management opened 0 new positions and closed 0 in Q1 2023.
  • MWG Management's portfolio value fell 27% quarter-over-quarter to $142M.

Based on MWG Management's 13F filing for Q1 2023, filed 15 May 2023.